aod9604 clinical trials obesity Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment Order AOD 9604 (3mg) |

The most common AEs reported during the study were: Headache (6 times) Fatigue (4) Hypoglycemia unspecified (3) Dizziness (3) Nasopharyngitis (2) Cough (2) Lethargy (1) Tonsillitis (1) Abdominal pain unspecified (1) Application site reaction unspecified (1) Injection site bruising (1) Rhinitis seasonal (1) Anorexia (1) Injection site pain (1) None of the AEs were of severe intensity and there was no observable trend between the different treatment groups with respect to the incidence of certain AEs

Complementary Treatments Many clients pair anti-fatigue vitamin therapy with other services for even more comprehensive support: IV nutrient therapy for larger doses of vitamins and hydration Facial treatments to address skin health from the outside in Ask your provider about combining services to help you look and feel your best

For many patients today this frequency however, would be a miracle

You have a right to know exactly what is being injected into your body